What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Interview Jul 19, 2024
Expanding the Alimentiv Site Network: An Interview With Peter Westerveld

The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring…

Publication Oct 18, 2018
A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score
Publication Sep 15, 2018
Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions
Publication Sep 8, 2018
Additional Stability Testing of Cryopreserved Intestinal Biopsies for Downstream Flow Cytometric Analysis
Publication Jul 26, 2018
2018 August Author Interview – Vipul Jairath
Publication Jul 11, 2018
Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy
Publication Jun 29, 2018
Physicians’ Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn’s Disease